Prospective evaluation of serum IL-16 and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Amy MooreWen-Yi HuangKim DanforthRoni FalkAllison MeadeRachel BagniSonja I Berndt

Published in: Cancer causes & control : CCC (2018)

This study found evidence that higher pre-diagnostic IL-16 levels may be associated with increased risk of high-grade disease, supporting inflammation as potential mechanism by which sexually transmitted diseases may increase risk.

Keyphrases

prostate cancer
high grade
radical prostatectomy
oxidative stress
low grade
clinical trial
phase iii
phase ii
randomized controlled trial